Poorest countries granted TRIPs extension

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Poorest countries granted TRIPs extension

Some of the world’s poorest countries will have access to affordable medicine for another eight years after WTO members agreed to extend the deadline for them to implement intellectual property provisions under the TRIPs Agreement.

Last week, the WTO issued a decision to extend the deadline for what it calls the “least developed countries” until July 1 2021, and said that a further extension may be possible when the time comes.

The previous deadline, which has already been extended once before, was July 1 2013.

The decision was made on the first day of a two-day meeting of the Trade-Related Aspects of Intellectual Property Rights (TRIPs) Council. Members unanimously agreed to the extension but had to resolve different views on the terms through negotiation.

At present, the WTO recognises 49 jurisdictions as “least developed countries”. Of these, 34 are members of the WTO.

The extension does not provide exempt the countries from their other obligations under the TRIPs Agreement, such as a separate transition period for them to protect patents covering pharmaceutical inventions.

“The agreement reached by members makes very clear that we can come together and get things done,” said WTO Director-General Pascal Lamy in a statement.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article